India delays Covid vaccine supplies to WHO-backed COVAX: Report

The world's biggest vaccine maker resumed exports of COVID-19 doses this month for the first time since April.

India too had opened diplomatic dialogues with the European Union (EU) after the EU Digital Covid Certificate framework recognised the AstraZeneca-Oxford vaccine, but not Covishield.

Premium

Reuters

2 min read Last Updated : Oct 19 2021 | 4:15 PM IST

India has delayed committing supplies of vaccine to the COVAX global sharing platform, two sources told Reuters on Tuesday, a day after one of its key backers, the WHO, said the agency could not "cut corners" to approve a domestically developed vaccine.

The world's biggest vaccine maker resumed exports of COVID-19 doses this month for the first time since April. It has sent about 4 million to countries such as neighbouring Bangladesh and Iran, but none to COVAX.

On Monday, in the run-up to an Oct. 26 meeting on Covaxin, India's first domestically developed COIVD-19 vaccine, the World Health Organization (WHO) said

Disclaimer: No Business Standard Journalist was involved in creation of this content

Topics : Coronavirus Coronavirus Tests Coronavirus Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in